Cellectar Biosciences, Inc. — Director's Dealing 2014

Aug 18, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2014-08-14

Reporting Person: BERNS PAUL L (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$7.80	2023-11-07	Common Stock (5000)		Direct

Footnotes

F1: Option vests in equal quarterly increments over a period of two years from the date of grant. Option expires on the tenth anniversary of the date of grant.